// Medicine ยท Glossary

Cannabinoid Neuroprotection Patent

๐Ÿฉบ Medicine First mentioned: Ep. 200

US Patent 6,630,507 held by the Department of Health and Human Services, which establishes cannabinoids as antioxidants and neuroprotectants. The patent proves the government's own research demonstrated therapeutic value of cannabinoids while simultaneously maintaining Schedule I classification.

Dr. David Allen discussed this extensively in Ep200. The patent office requires every comma to be exactly correct โ€” they won't issue a patent number if anything is incorrect. The patent proves cannabinoids have neuroprotective properties, directly contradicting the Schedule I claim of 'no accepted medical use.' The contradiction between the government holding this patent and maintaining prohibition was a major theme. Scientific articles and patents were described as the keeper of truth.

Ep. 200 Hash Church 200 โ†’